Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.940
+0.100 (3.52%)
At close: Apr 24, 2026, 4:00 PM EDT
2.970
+0.030 (1.02%)
After-hours: Apr 24, 2026, 7:57 PM EDT

NRx Pharmaceuticals Revenue

In the year 2025, NRx Pharmaceuticals had annual revenue of $1.23M. NRx Pharmaceuticals had revenue of $983.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$1.23M
Revenue Growth
n/a
P/S Ratio
79.28
Revenue / Employee
$42,241
Employees
29
Market Cap
97.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.23M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Q32 Bio53.74M
Gossamer Bio48.47M
Coya Therapeutics7.95M
Rani Therapeutics Holdings1.63M
Coeptis Therapeutics Holdings1.36M
Inovio Pharmaceuticals65.34K
Fractyl Health3.00K
Revenue Rankings

NRXP News

More News